Category:
Other Excipients
CAS NO:
/
Standard:
In-house Standards,

In the treatment of acute cerebral infarction. "Highlights: 1, The smallest molecular weight among similar products: (1). High bioavailability; (2). Weak Antigenic activity; 2, Half-life up to 20hours: Continuous and stable thrombolysis and inhibition of thrombus; 3, Safe clinical application: Low side effects; 4, Protection against ischemia-reperfusion injury 5, Time to market: 2002 6, Exported countries: Vietnam Registration Dossiers:non-clinical & clinical part, drug substance part and drug product part."